The ECLA/PHRI Intervention in the Community Trial

NAUnknownINTERVENTIONAL
Enrollment

2,490

Participants

Timeline

Start Date

November 14, 2022

Primary Completion Date

April 14, 2023

Study Completion Date

June 30, 2023

Conditions
Hypertension
Interventions
DIETARY_SUPPLEMENT

Salt substitute 66%33%

Salt substitute composed of 66% potassium chloride and 33% sodium chloride

DIETARY_SUPPLEMENT

Salt substitute 33%/66%

Salt substitute composed of 33% potassium chloride and 66% sodium chloride

Trial Locations (1)

2000

RECRUITING

IIC-Instituto de Investigaciones Clínicas, Rosario

Sponsors
All Listed Sponsors
collaborator

Population Health Research Institute

OTHER

lead

Estudios Clínicos Latino América

OTHER

NCT05638009 - The ECLA/PHRI Intervention in the Community Trial | Biotech Hunter | Biotech Hunter